IPO-bound e-pharmacy brand and healthcare app: PharmEasy signs up Bollywood actor Aamir Khan as brand ambassador
- ByStartupStory | April 2, 2022
Pharmeasy, IPO-bound e-pharmacy brand and healthcare app, has announced the appointment of Bollywood actor Aamir Khan as its brand ambassador. As part of IPL 2022, the partnership will include endorsement across mediums, including TV commercials featuring Aamir Khan.
Aamir Khan said in a statement issued by the company that to work together with the PharmEasy brand is indeed a pleasure, to help provide economical healthcare at each person’s doorstep. He feels PharmEasy is providing an essential service, in a sector that is itself a fundamental requirement for all of us, in today’s times, and he is looking forward to this association.
On the PharmEasy app, Aamir Khan will promote the ease of availability of medicines, diagnostic tests and healthcare products, as the face of the brand. In making healthcare accessible to every nook and corner of the country, collaborating with Aamir Khan will further strengthen the brand’s belief, said a statement issued by the company.
Gaurav Verma, CMOT at API Holdings, the parent company of PharmEasy brand said that collaborating with someone as versatile as Aamir Khan fills us with immense joy. As the face of the brand PharmEasy, they are absolutely thrilled to have him on board. He truly knows how to engage with the audience.
He further added that they aim to reach more people while making affordable healthcare accessible to everyone, with this association. This year, they are looking forward to a great collaboration with him and widening our reach through offerings and such campaigns.
In November 2021, API Holdings filed the Draft Red Herring Prospectus (DRHP) to raise Rs 6,250 crore through an initial public offering through primary share sale. Through a pre-IPO round which will bring down the fresh issue size, the company is in conversation with bankers to raise Rs 1,250 crore. However, a delay in the company’s plan to list publicly has been pointed out by the recent media reports.
Rs 1,500 crore Towards inorganic growth and strategic investments the company has also earmarked.
Follow Startup Story
Related Posts
